Adverum Biotechnologies, Inc.
Symbol: ADVM
NASDAQ
10.43
USDMarktpreis heute
-0.9010
P/E-Verhältnis
0.0140
PEG-Verhältnis
216.47M
MRK Kapital
- 0.00%
DIV Rendite
Adverum Biotechnologies, Inc. (ADVM) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 519.35 | 96.5 | 185.6 | 305.2 | ||||||||||||
balance-sheet.row.short-term-investments | 160.24 | 21.5 | 117.2 | 271 | ||||||||||||
balance-sheet.row.net-receivables | 0 | 0 | 0 | 5.7 | ||||||||||||
balance-sheet.row.inventory | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.other-current-assets | 24.04 | 6.2 | 5 | 6.2 | ||||||||||||
balance-sheet.row.total-current-assets | 543.38 | 102.8 | 190.6 | 317.1 | ||||||||||||
balance-sheet.row.property-plant-equipment-net | 328.46 | 67 | 113.9 | 119.1 | ||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.long-term-investments | 9.78 | 2 | 2.5 | 3.3 | ||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.other-non-current-assets | 5.16 | 1.2 | 1.4 | 0.3 | ||||||||||||
balance-sheet.row.total-non-current-assets | 343.4 | 70.2 | 117.8 | 122.6 | ||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-assets | 886.79 | 173 | 308.4 | 439.7 | ||||||||||||
balance-sheet.row.account-payables | 8.37 | 1.9 | 2.2 | 1.4 | ||||||||||||
balance-sheet.row.short-term-debt | 72.39 | 10.4 | 13.2 | 1.9 | ||||||||||||
balance-sheet.row.tax-payables | 0.54 | 0.1 | 0.3 | 1.3 | ||||||||||||
balance-sheet.row.long-term-debt-total | 266.93 | 64.6 | 93.6 | 101.1 | ||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||
balance-sheet.row.other-current-liab | 33.49 | 12.5 | 16.8 | 2 | ||||||||||||
balance-sheet.row.total-non-current-liabilities | 266.93 | 64.6 | 94.6 | 102.2 | ||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.capital-lease-obligations | 328.92 | 64.6 | 106.8 | 103 | ||||||||||||
balance-sheet.row.total-liab | 411.69 | 89.5 | 126.9 | 123.5 | ||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.common-stock | 0.04 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.retained-earnings | -3510.69 | -919.8 | -802.6 | -648.1 | ||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -2.43 | -0.5 | -1.5 | -0.7 | ||||||||||||
balance-sheet.row.other-total-stockholders-equity | 3988.17 | 1003.7 | 985.7 | 965 | ||||||||||||
balance-sheet.row.total-stockholders-equity | 475.1 | 83.5 | 181.5 | 316.2 | ||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 886.79 | 173 | 308.4 | 439.7 | ||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-equity | 475.1 | 83.5 | 181.5 | 316.2 | ||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 886.79 | - | - | - | ||||||||||||
Total Investments | 162.22 | 23.5 | 117.2 | 271 | ||||||||||||
balance-sheet.row.total-debt | 339.32 | 75 | 106.8 | 103 | ||||||||||||
balance-sheet.row.net-debt | -19.78 | 0 | 38.4 | 68.8 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -117.17 | -117.2 | -154.5 | -145.5 | ||||||||||||
cash-flows.row.depreciation-and-amortization | 5.64 | 5.6 | 6.5 | 4.6 | ||||||||||||
cash-flows.row.deferred-income-tax | -7.26 | 0.4 | 0 | 3.8 | ||||||||||||
cash-flows.row.stock-based-compensation | 17.57 | 17.6 | 20.1 | 25.2 | ||||||||||||
cash-flows.row.change-in-working-capital | -8.32 | -8.3 | 19.9 | 4.1 | ||||||||||||
cash-flows.row.account-receivables | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.inventory | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.account-payables | -0.37 | -0.4 | 0.8 | -1.6 | ||||||||||||
cash-flows.row.other-working-capital | -7.95 | -7.9 | 19 | 5.7 | ||||||||||||
cash-flows.row.other-non-cash-items | 18.55 | 10.6 | -0.1 | 0 | ||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -90.98 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -0.81 | -0.8 | -11.8 | -15.1 | ||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.purchases-of-investments | -36.72 | -36.7 | -104.4 | -407.5 | ||||||||||||
cash-flows.row.sales-maturities-of-investments | 134.4 | 134.4 | 257.9 | 501.3 | ||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 96.88 | 96.9 | 141.7 | 78.7 | ||||||||||||
cash-flows.row.debt-repayment | -2.34 | 0 | -13.6 | -0.2 | ||||||||||||
cash-flows.row.common-stock-issued | 0.49 | 0.5 | 0 | 1.7 | ||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.other-financing-activites | 1.06 | -0.4 | 14.2 | 1 | ||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -0.72 | 0.5 | 0.6 | 2.4 | ||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 1.54 | 0.5 | 0 | 0 | ||||||||||||
cash-flows.row.net-change-in-cash | 6.72 | 6.6 | 34.2 | -26.7 | ||||||||||||
cash-flows.row.cash-at-end-of-period | 366.91 | 75 | 70.9 | 36.7 | ||||||||||||
cash-flows.row.cash-at-beginning-of-period | 360.19 | 68.4 | 36.7 | 63.4 | ||||||||||||
cash-flows.row.operating-cash-flow | -90.98 | -91.3 | -108.1 | -107.8 | ||||||||||||
cash-flows.row.capital-expenditure | -0.81 | -0.8 | -11.8 | -15.1 | ||||||||||||
cash-flows.row.free-cash-flow | -91.79 | -92.1 | -119.9 | -123 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 3.6 | 3.6 | 0 | 7.5 | ||||||||||||
income-statement-row.row.cost-of-revenue | 12.58 | 5.6 | 6.5 | 4.6 | ||||||||||||
income-statement-row.row.gross-profit | -8.98 | -2 | -6.5 | 2.9 | ||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.research-development | 77.48 | - | - | - | ||||||||||||
income-statement-row.row.selling-general-administrative | 49.91 | - | - | - | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | -1.01 | - | - | - | ||||||||||||
income-statement-row.row.other-expenses | 5.75 | 5.7 | 2.7 | 0.6 | ||||||||||||
income-statement-row.row.operating-expenses | 126.38 | 121.7 | 157.1 | 153.6 | ||||||||||||
income-statement-row.row.cost-and-expenses | 127.39 | 127.4 | 157.1 | 153.6 | ||||||||||||
income-statement-row.row.interest-income | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.interest-expense | -1.2 | 0 | -2.7 | 0 | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | -1.01 | - | - | - | ||||||||||||
income-statement-row.row.total-other-income-expensenet | 5.55 | 5.5 | 2.7 | 0.6 | ||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-operating-expenses | 5.75 | 5.7 | 2.7 | 0.6 | ||||||||||||
income-statement-row.row.total-operating-expenses | 5.55 | 5.5 | 2.7 | 0.6 | ||||||||||||
income-statement-row.row.interest-expense | -1.2 | 0 | -2.7 | 0 | ||||||||||||
income-statement-row.row.depreciation-and-amortization | 5.64 | 5.6 | 6.5 | 4.6 | ||||||||||||
income-statement-row.row.ebitda-caps | -118.15 | - | - | - | ||||||||||||
income-statement-row.row.operating-income | -123.79 | -123.8 | -157.1 | -146.1 | ||||||||||||
income-statement-row.row.income-before-tax | -118.24 | -118.2 | -154.5 | -145.5 | ||||||||||||
income-statement-row.row.income-tax-expense | -1.08 | -1.1 | 0.1 | 0 | ||||||||||||
income-statement-row.row.net-income | -117.17 | -117.2 | -154.5 | -145.5 |
Häufig gestellte Frage
Wie hoch ist die Adverum Biotechnologies, Inc. (ADVM) Gesamtvermögen?
Adverum Biotechnologies, Inc. (ADVM) Gesamtvermögen ist 173010000.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist N/A.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist -2.494.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist -9.069.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist -32.546.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist -34.386.
Was ist der Adverum Biotechnologies, Inc. (ADVM) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist -117165000.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 75036000.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 121747000.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 75000000.000.